blonder8k051911.htm
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549



FORM 8-K
 
Current Report Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934



Date of Report (Date of earliest event reported): May 18, 2011
 
 
               Blonder Tongue Laboratories, Inc.                
(Exact Name of registrant as specified in its charter)
 
 
 
           Delaware            
(State or other jurisdiction of incorporation)
 
 
 
        1-14120        
(Commission File Number)
 
 
 
         52-1611421          
(I.R.S. Employer Identification No.)
 
 
  One Jake Brown Road, Old Bridge, New Jersey  08857   
(Address of principal executive offices)  (Zip Code)
 
 
 
Registrant’s telephone number, including area code:   (732) 679-4000        
 
 
                                  Not Applicable                            
(Former name or former address, if changed since last report)

 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
 
[_] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
 
[_] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
 
[_] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
 
[_] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 

 
 
 

Item 5.07                          Submission of Matters to a Vote of Security Holders.
 
 
The 2011 Annual Meeting of Stockholders (“2011 Annual Meeting”) of Blonder Tongue Laboratories, Inc. (the “Company”) was held on May 18, 2011.  On March 31, 2011, the record date for the Annual Meeting, 6,208,889 shares of the Company’s common stock were outstanding and entitled to one vote per share upon all matters submitted at the 2011 Annual Meeting.  At the 2011 Annual Meeting, Anthony J. Bruno, Steven L. Shea and James A. Luksch were elected to serve as directors of the Company for three-year terms to expire at the 2014 annual meeting of shareholders. These directors were elected by the following votes:
 

DIRECTORS
  
FOR
  
WITHHELD
  
BROKER NON-VOTE
Anthony J. Bruno
  
4,195,137
  
      194,714
  
1,109,136
Steven L. Shea
  
4,193,637
  
      196,214
  
1,109,136
James A. Luksch
  
3,863,130
  
      526,721
  
1,109,136


The following proposal was also approved at the annual meeting:

Proposal 2: The stockholders approved a proposal to ratify the appointment of Marcum LLP, certified public accountants, as the Company’s independent registered public accountants for the year ending December 31, 2011.


FOR
  
AGAINST
  
ABSTAIN
  
BROKER NON-VOTE
5,474,914
  
6,501
  
2,742
  
14,830


 

 
Item 9.01.  Financial Statements and Exhibits
 
(a)  
Not applicable
 
(b)  
Not applicable
 
(c)  
Not applicable
 
(d)  
The following exhibits are filed herewith:
 
Exhibit 99.1                           Form of Option Agreement under the 2005 Employee Equity Incentive Plan, as amended, approved May 18, 2011.
 
Exhibit 99.2                           Form of Option Agreement under the 2005 Director Equity Incentive Plan, as amended, approved May 18, 2011.
 
 
2
 
 
 
 
 
 
SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
BLONDER TONGUE LABORATORIES, INC.



By:        /s/ Eric Skolnik                                                       
     Eric Skolnik
     Senior Vice President and Chief Financial Officer
 
Date: May 20, 2011


3